Loading…
Solesis announced plans to build a new manufacturing site in Costa Rica, its first in the country, dedicated to producing implantable textile components, polymer-based devices, and single-use technologies for the medical device and biopharmaceutical industries. The facility is scheduled to begin operations in spring 2025.
Solesis, an advanced biomaterials company, acquired Polyzen, a contract developer and manufacturer of medical-grade polymer components. Polyzen will operate as a subsidiary of Solesis.
| Site | Largest | Latest |
|---|---|---|
| Greenpark Free Trade Zone, Costa Rica | 2024-01-01 |